EasySep™小鼠TIL（CD45）正选试剂盒
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
很抱歉, 生成此内容时发生错误。
沪公网安备31010102008431号